NHLRC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.69829763772145E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.84139997589017E-09 |
Normal-vs-Stage2 |
1.99952999999642E-05 |
Normal-vs-Stage3 |
3.06899999968913E-07 |
Normal-vs-Stage4 |
6.209200E-04 |
Stage1-vs-Stage2 |
7.901200E-01 |
Stage1-vs-Stage3 |
8.795800E-01 |
Stage1-vs-Stage4 |
9.815400E-01 |
Stage2-vs-Stage3 |
8.879000E-01 |
Stage2-vs-Stage4 |
8.425800E-01 |
Stage3-vs-Stage4 |
9.012400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.52729964628418E-10 |
Normal-vs-AfricanAmerican |
1.27260000315488E-08 |
Normal-vs-Asian |
2.170800E-04 |
Caucasian-vs-AfricanAmerican |
9.835600E-01 |
Caucasian-vs-Asian |
4.081400E-01 |
AfricanAmerican-vs-Asian |
3.661000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.63447033685316E-12 |
Normal-vs-Female |
7.184300E-04 |
Male-vs-Female |
5.367800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.58929999999335E-05 |
Normal-vs-Extreme_Weight |
8.20776779875132E-12 |
Normal-vs-Obese |
3.14020000002913E-08 |
Normal-vs-Extreme_Obese |
3.67310000000121E-05 |
Normal_Weight-vs-Extreme_Weight |
1.481010E-01 |
Normal_Weight-vs-Obese |
7.313000E-01 |
Normal_Weight-vs-Extreme_Obese |
5.811200E-01 |
Extreme_Weight-vs-Obese |
2.111800E-02 |
Extreme_Weight-vs-Extreme_Obese |
8.221600E-01 |
Obese-vs-Extreme_Obese |
3.070200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.178800E-04 |
Normal-vs-Age(41-60Yrs) |
4.27120000034975E-07 |
Normal-vs-Age(61-80Yrs) |
1.5780710072022E-12 |
Normal-vs-Age(81-100Yrs) |
3.5597000003218E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.669000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.925800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.444610E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.528000E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.766090E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.203600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.02970973361971E-12 |
Normal-VS-Type2 PRCC |
1.12699999998966E-07 |
Normal-VS-KIRP CIMP |
1.507870E-02 |
Normal-VS-Unclassified PRCC |
4.764800E-04 |
Type1 PRCC-VS-Type2 PRCC |
1.346810E-01 |
Type1 PRCC-VS-KIRP CIMP |
9.123700E-02 |
Type1 PRCC-VS-Unclassified PRCC |
6.338100E-02 |
Type2 PRCC-VS-KIRP CIMP |
3.708200E-01 |
Type2 PRCC-VS-Unclassified PRCC |
3.588000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
8.076400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.07239772617618E-11 |
Normal-vs-N1 |
2.23969999999518E-05 |
Normal-vs-N2 |
1.471960E-02 |
N0-vs-N1 |
1.302160E-01 |
N0-vs-N2 |
7.013200E-01 |
N1-vs-N2 |
7.766000E-01 |
|
|